Treating eczema and/or psoriasis
OwnerTimothy David Meakin, Dianne Cadwallader +1inventors
InventorsTimothy David Meakin, Dianne Cadwallader, Craig Leonard Healtley
Life of this patent
Estimating the term…
Abstract
The treatment of humans or other mammals for eczema and/or psoriasis using dosage forms or compositions that include cetyl myristate alone or (in admixture or serially) both cetyl myristate and cetyl palmitate.
Claims32
A method of treatment and/or prophylaxis of a mammal for eczema and/or psoriasis which comprises or includes administering or having self administered to such mammal an effective amount of either
- (a) cetyl myristate, or
- (b) cetyl myristate and cetyl palmitate.
A method of any one of the preceding claims wherein said effective amount of (a) or (b) is by means of one or more capsules.
A method of any one of the preceding claims where said mammal is a human being suffering from eczema and the administration is for treatment purposes.
A method of any one of the preceding claims where both cetyl myristate and cetyl palmitate in admixture are administered, the ratio by weight to weight being 95:5 respectively.
A method of treatment of a human being for eczema which comprises or includes having administered to that human an effective amount of cetyl myristate.
A method of treatment of a human being for psoriasis which comprises or includes having administered to that human an effective amount of cetyl myristate.
An oral pharmaceutical composition for treating eczema which comprises or includes both cetyl myristate and cetyl palmitate.
An oral pharmaceutical composition for treating psoriasis which comprises or includes both cetyl myristate and cetyl palmitate.
An oral dosage unit effective in the treatment of eczema and/or psoriasis, said dosage unit having either
- (a) cetyl myristate, or
- (b) a mixture of cetyl myristate and cetyl palmitate.
The use, in the manufacture of oral dosage units for the treatment or prophylaxis of eczema and/or psoriasis in a mammal, of
- (a) cetyl myristate, or
- (b) a mixture of cetyl myristate and cetyl palmitate, or
- (c) cetyl palmitate.
The use, in the manufacture of oral dosage units for the treatment or prophylaxis of eczema and/or psoriasis in a mammal, of
- (i) cetyl myristate and
- (ii) cetyl palmitate.
Dependencies are inferred from the claim text.